The FDA cautions both consumers and retailers against consuming, selling, or offering for sale any microdosing chocolate bars from the Diamond Shruumz brand due to multiple hospitalizations reported across four states.
According to an advisory from the FDA, eight individuals have reported feeling unwell after consuming chocolates from Diamond Shruumz. Among these cases, six people required hospitalisation. The affected individuals are distributed across four states: four in Arizona, two in Indiana, one in Nevada, and one in Pennsylvania.
The FDA stated that individuals who ingested the chocolate bars have reported various symptoms, such as seizures, central nervous system depression (manifested as loss of consciousness, confusion, and drowsiness), agitation, irregular heart rates, high and low blood pressure, as well as nausea and vomiting.
There have been no reported fatalities associated with the consumption of these products.
Micro-dosing involves the practice of consuming minimal amounts of psychedelic substances such as psilocybin mushrooms. Advocates of micro-dosing claim that these small doses can enhance mood and focus.
As per information provided on the company’s website, Diamond Shruumz’s chocolate bars are crafted using a unique combination of nootropic and functional mushrooms. It’s emphasised that these products do not include substances like psilocybin, amanita, or any regulated drugs.
CNN has attempted to reach out to Diamond Shruumz for comment but has not received a response at the time of publishing.
Despite the FDA’s advisory, Diamond Shruumz has continued to share promotional content on their Instagram and TikTok profiles without acknowledging the reported illnesses.
If you or someone you know experiences symptoms after consuming Diamond Shruumz’s chocolate bars, the FDA advises consulting a healthcare provider and/or contacting the Poison Help Line at 1-800-222-1222.
